-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
2seventy bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2024.
- 2seventy bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.9M, a 82.1% increase year-over-year.
- 2seventy bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$152M, a 25.8% increase year-over-year.
- 2seventy bio, Inc. annual Operating Income (Loss) for 2023 was -$238M, a 9.7% increase from 2022.
- 2seventy bio, Inc. annual Operating Income (Loss) for 2022 was -$263M, a 16.2% increase from 2021.
- 2seventy bio, Inc. annual Operating Income (Loss) for 2021 was -$314M, a 127% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)